Pembrolizumab and Interferon Gamma-1b in Treating Patients With Stage IB-IVB Relapsed or Refractory Mycosis Fungoides and Sezary Syndrome
Conditions: Recurrent Mycosis Fungoides and Sezary Syndrome; Refractory Mycosis Fungoides; Stage IB Mycosis Fungoides and Sezary Syndrome; Stage II Mycosis Fungoides and Sezary Syndrome; Stage IIA Mycosis Fungoides and Sezary Syndrome; Stage IIB Mycosis Fungoides and Sezary Syndrome; Stage III Mycosis Fungoides and Sezary Syndrome; Stage IIIA Mycosis Fungoides and Sezary Syndrome; Stage IIIB Mycosis Fungoides and Sezary Syndrome; Stage IV Mycosis Fungoides and Sezary Syndrome; Stage IVA Mycosis Fungoides and Seza ry Syndrome; ...
Source: ClinicalTrials.gov - February 22, 2017 Category: Research Source Type: clinical trials
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
< b > Conditions < /b > : Mycosis Fungoides; Non-Hodgkin's Lymphoma < br/ > < b > Intervention < /b > : < br/ > < b > Sponsor < /b > : Stanford University < br/ > < b > Not yet recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2016 Category: Research Source Type: clinical trials